Search - tctmd.com

Displaying 981 - 1000 of 4671

Sort: Relevancy | Date

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

News Daily News

No Increased MACE Following COVID-19 Vaccination in Adults With CVD

Yael L. Maxwell

June 24, 2022

FDA Plans to Slash Nicotine Levels in Cigarettes and Other Products

News Daily News

FDA Plans to Slash Nicotine Levels in Cigarettes and Other Products

Michael O'Riordan

June 23, 2022

Large Study Confirms Clot Risks With Oxford/AstraZeneca COVID-19 Vaccine

News Daily News

Large Study Confirms Clot Risks With Oxford/AstraZeneca COVID-19 Vaccine

June 15, 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

COVID-19: TCTMD’s Dispatch for June Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for June Week 3

June 13, 2022

TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials

Presentation TVT 2022

TVARC Safety and Efficacy Endpoint Recommended for Clinical Trials

Presenter: Mahesh V. Madhavan

June 10, 2022

TV Repair Will Dominate: Safety Will Always Prevail!

Presentation TVT 2022

TV Repair Will Dominate: Safety Will Always Prevail!

Presenter: Paul Sorajja

June 10, 2022

Catheter Ablation May Be Underused for Supraventricular Tachycardia

News Daily News

Catheter Ablation May Be Underused for Supraventricular Tachycardia

June 10, 2022

Presentation TVT 2022

Post-Approval Safety Profile of Amulet vs Watchman FLX Left Atrial Appendage Closure Devices: Analysis from the MAUDE Database (ALERT-MAUDE Study)

Presenter: Poonam Velagapudi

June 10, 2022

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

News Daily News

Short-term Testosterone Use Doesn’t Spur CV Events: Meta-analysis

June 10, 2022

Proven Safety through MitraClip G4 and Evolution of TEER

Presentation TVT 2022

Proven Safety through MitraClip G4 and Evolution of TEER

Presenter: Rahul Sharma

June 09, 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis

Presentation TVT 2022

Safety and Efficacy of Transcatheter Aortic Valve Replacement in Patients with Bicuspid versus Tricuspid Aortic Valve Stenosis: A Metanalysis

Presenter: Yasser Radwan

June 09, 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presentation TVT 2022

EFFICACY AND SAFETY OUTCOMES OF CEREBRAL EMBOLIC PROTECTION DEVICES DURING TRANSCATHETER AORTIC VALVE REPLACEMENT: AN UPDATED META-ANALYSIS

Presenter: Arpanjeet Kaur

June 08, 2022

TCTMD Reporters, Blogger Honored With Digital Health Awards

News Opinion Editor's Corner

TCTMD Reporters, Blogger Honored With Digital Health Awards

June 07, 2022

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

June 01, 2022

June 2022 News Roundup

News Opinion CV Team Dispatch

June 2022 News Roundup

June 01, 2022

Aficamten Safe, Effective for Up to 6 months in Obstructive HCM: REDWOOD-HCM OLE

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

May 31, 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

News Conference News SCAI 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

May 23, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.